This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Skip to main content
United Kingdom | EN-GB

Add a bookmark to get started

Cortex - Life Sciences Insights

| less than a minute read

Digital Therapeutics - evolution and entry into mainstream healthcare

This international report on "Digital Therapeutics - Evolution and entry into mainstream healthcare" was recently published jointly by DLA Piper and The Lawyer. The report discusses the current developments and key global issues in this field from the perspective of M&A/corporate, litigation, data protection, IPT and life sciences regulatory, among others.

Despite all regulatory challenges, the critical role of physicians in determining the success of digital therapeutics cannot be stressed enough.


healthtech, medical devices, digital therapeutics, digital health, life sciences, pharmaceuticals, m&a, ip rights, data protection, regulatory law, litigation